MENU
+Compare
MED
Stock ticker: NYSE
AS OF
Oct 22 closing price
Price
$12.64
Change
-$0.23 (-1.79%)
Capitalization
138.93M

MED Medifast Forecast, Technical & Fundamental Analysis

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life... Show more

MED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MED with price predictions
Oct 22, 2025

MED sees MACD Histogram just turned negative

MED saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 10, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 54 instances where the indicator turned negative. In of the 54 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MED as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

MED moved below its 50-day moving average on October 10, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MED crossed bearishly below the 50-day moving average on October 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MED entered a downward trend on October 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for MED's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MED advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

MED may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.643) is normal, around the industry mean (9.275). P/E Ratio (38.303) is within average values for comparable stocks, (20.411). MED's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.561). MED has a moderately high Dividend Yield (0.089) as compared to the industry average of (0.042). P/S Ratio (0.289) is also within normal values, averaging (636.250).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MED’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

View a ticker or compare two or three
MED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MED is expected to report earnings to fall 236.36% to -30 cents per share on November 03

Medifast MED Stock Earnings Reports
Q3'25
Est.
$-0.30
Q2'25
Beat
by $0.44
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.24
Q3'24
Beat
by $0.63
The last earnings report on August 04 showed earnings per share of 21 cents, beating the estimate of -21 cents. With 147.84K shares outstanding, the current market capitalization sits at 138.93M.
A.I.Advisor
published Dividends

MED paid dividends on November 07, 2023

Medifast MED Stock Dividends
А dividend of $1.65 per share was paid with a record date of November 07, 2023, and an ex-dividend date of September 18, 2023. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health and diet products

Industry PersonnelServices

Profile
Fundamentals
Details
Industry
Specialty Stores
Address
100 International Drive
Phone
+1 410 581-8042
Employees
634
Web
https://www.medifastinc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPXGF8.870.18
+2.07%
Cineplex, Inc.
HBSI38.66N/A
N/A
Highlands Bankshares, Inc.
NNDNF18.58N/A
N/A
Nidec Corp.
SIGY1.99N/A
N/A
Sigyn Therapeutics Inc.
ROYUF73.11N/A
N/A
Royal Unibrew A S

MED and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MED has been loosely correlated with EXPE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MED jumps, then EXPE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MED
1D Price
Change %
MED100%
-1.79%
EXPE - MED
36%
Loosely correlated
+0.11%
CSV - MED
31%
Poorly correlated
-0.29%
FTDR - MED
24%
Poorly correlated
+0.62%
TNL - MED
23%
Poorly correlated
+15.23%
MCW - MED
23%
Poorly correlated
-2.46%
More

Groups containing MED

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MED
1D Price
Change %
MED100%
-1.79%
Commercial Services
category (188 stocks)
20%
Poorly correlated
-1.16%
Personnel Services
category (23 stocks)
16%
Poorly correlated
-1.23%